Order Article Reprints

Agulnik JS, Papadakis AI, Pepe C, Sakr L, Small D, Wang H, Kasymjanova G, Spatz A, Cohen V. Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC). Current Oncology. 2022; 29(2):1107-1116. https://doi.org/10.3390/curroncol29020094

Agulnik, Jason S., Andreas I. Papadakis, Carmela Pepe, Lama Sakr, David Small, Hangjun Wang, Goulnar Kasymjanova, Alan Spatz, and Victor Cohen. 2022. "Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)" Current Oncology 29, no. 2: 1107-1116. https://doi.org/10.3390/curroncol29020094

Agulnik, J. S., Papadakis, A. I., Pepe, C., Sakr, L., Small, D., Wang, H., Kasymjanova, G., Spatz, A., & Cohen, V. (2022). Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC). Current Oncology, 29(2), 1107-1116. https://doi.org/10.3390/curroncol29020094